We are live on ! Find out more
KERX

Keryx Biopharmaceuticals Inc
KERX

Delisted

KERX was delisted on the 12th of December, 2018.

Back to rankings

1 hedge funds and large institutions have $3 invested in Keryx Biopharmaceuticals Inc in 2026 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

0% more capital invested

Capital invested by funds: $3 → $3 ($0)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
HNB
1
Huntington National Bank
Ohio
$3 – – –

KERX Hedge Fund Activity: Q1 2026 in Review

1 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Keryx Biopharmaceuticals Inc (KERX) for Q1 2026, worth a combined $3 — unchanged from a quarter earlier.

Fund positioning in KERX was balanced in Q1 2026: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held Keryx Biopharmaceuticals Inc (KERX) as of Q1 2026, unchanged from Q4 2025.
  • Funds reported $3 of Keryx Biopharmaceuticals Inc stock for Q1 2026, unchanged quarter-over-quarter.
  • 0 funds opened new Keryx Biopharmaceuticals Inc positions in Q1 2026 and 0 closed out.

Based on aggregated 13F filings for Q1 2026.